![Colin Scott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Colin Scott was Vice President of Clinical Research and Development for NovaBay Pharmaceuticals, Inc. from January 2006 to December 31, 2008.
From October 2004 to December 2005, he was Vice President-Drug Development for GlycoMimetics.
From June 2004 to September 2004, Dr. Scott was a Consultant to several biopharmaceutical companies.
From September 2002 to May 2004, he served as the Vice President-Clinical and Regulatory at Arriva Pharmaceuticals, Inc. From March 2001 to May 2002, Dr. Scott served as Vice President-Clinical of Emisphere Technologies, Inc. He received a Medical degree in Pulmonology and Infectious Diseases from Glasgow University in Scotland.
Former positions of Colin Scott
| Companies | Position | End |
|---|---|---|
| STABLECOIN DEVELOPMENT CORPORATION | Chief Tech/Sci/R&D Officer | 31/12/2008 |
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Corporate Officer/Principal | 01/12/2005 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Chief Tech/Sci/R&D Officer | 01/05/2004 |
| EMISPHERE TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 01/05/2002 |
Training of Colin Scott
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
NovaBay Pharmaceuticals, Inc.
 NovaBay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and sale of eye and wound care products | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
- Stock Market
- Insiders
- Colin Scott
